4
Changes in Ownership
Lexeo Therapeutics, Inc. Filed Acc 0001415889-24-023233
Chief Executive Officer sold 5,000 shares at $10.65 ($53,274)
- Chief Executive Officer acquired 5,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Townsend Richard Nolan · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-09-10 | Exercise or conversion : show line 1 in the form 10b5-1 | +5,000 | $2.33 | $11,650 | 125,695 | D |
| 2024-09-10 | Sale : show line 2 in the form 10b5-1 | −5,000 | $10.65 | $53,274 | 120,695 | D |
| Open-market sales · 5,000 sh · avg $10.65 · $53,274 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-09-10 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (right to buy) | −5,000 | 128,655 | D |
Loading xslF345X05/form4-09112024_090900.xml…